Posted in | News | Chemical Sensor

Multiple Global Regulatory Approvals for Morpho Itemiser DX

Morpho Detection, which is the detection wing of the Safran Group’s Security Unit, Morpho, declared that five global regulatory agencies have approved its advanced desktop explosives and narcotics detection product, the Itemiser DX. More than 3000 units have been sold so far.

Morpho Detection, Inc., the detection business of Morpho, Safran group's security unit, has announced its advanced technology, desktop explosives and narcotics detection solution, Itemiser(R) DX, has been approved by five global regulatory agencies and has sold more than 3,000 units.

The Itemiser DX, which was launched in 2009, has been granted approval from the U.K. Home Office Scientific Development Branch (HOSDB), U.K. Department for Transport, the Italian Department of Transport, the Israeli Prime Minister’s Office and the U.S. Transportation Security Administration (TSA).

This device is the latest version of the Itemiser desktop product family and is the first trace detector to detect both positive and negative ions simultaneously. This detection helps the Itemiser DX to identify a diverse range of explosives that are prevalent in the market. The compact and user-friendly solution can instantly detect both explosives and narcotics simultaneously in a portable and ergonomic package.

Dennis Cooke, who is the CEO and President of Morpho, stated that the company is very happy that the Itemiser DX had received authorizations from the regulatory agencies worldwide. He remarked that the Itemiser DX could deliver advanced explosives detection at commercial and government high risk facilities, air cargo, checkpoints and checked bag screening outlets at airports.

The Ion Trace Mobility Spectrometer (ITMS) device is not only easy to use, but is also cost-effective and reliable. This technology provides unmatched threat detection at checkpoints, checked baggage screening and air cargo counters. The device is also available in a commercial version, which would safeguard all intermodal transportation modes, high risk government and commercial and industrial facilities and other locations. It would also prove to be the perfect complement to the CT based 9800 and CTX 5800 explosives detection systems, which are used for handling large air cargo and break bulk cargo screening. Over 2800 Itemiser DX units have been ordered by the U.S. TSA, with a total contract valued at $83 million.

This device uses a new, durable positive ion dopant, which could detect a broad range of explosives such as homemade peroxide-based substances, which were used in the London terror attacks. The Itemiser DX could also be customized to suit the needs of customers. Currently, it is being showcased at the Safran Stand Hall 2A, B254 at the Paris Air Show from June 20 to 26, 2011.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Choi, Andy. (2019, February 24). Multiple Global Regulatory Approvals for Morpho Itemiser DX. AZoSensors. Retrieved on November 22, 2024 from https://www.azosensors.com/news.aspx?newsID=2842.

  • MLA

    Choi, Andy. "Multiple Global Regulatory Approvals for Morpho Itemiser DX". AZoSensors. 22 November 2024. <https://www.azosensors.com/news.aspx?newsID=2842>.

  • Chicago

    Choi, Andy. "Multiple Global Regulatory Approvals for Morpho Itemiser DX". AZoSensors. https://www.azosensors.com/news.aspx?newsID=2842. (accessed November 22, 2024).

  • Harvard

    Choi, Andy. 2019. Multiple Global Regulatory Approvals for Morpho Itemiser DX. AZoSensors, viewed 22 November 2024, https://www.azosensors.com/news.aspx?newsID=2842.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.